The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EBMT-EHA CAR-T 2019 | A key take-home message from the EBMT-EHA CAR T-Cell Meeting
Here, Graham Collins, MBBS, MRCP, FRCPath, DPhil, of the Oxford University Hospitals NHS Foundation Trust, Oxford, UK, describes the most exciting aspect of CAR T-cell therapy currently. Speaking at the 1st European CAR T-Cell Meeting, held in Paris, France, Dr Collins explains the key issues with CAR T-cell therapy and the interesting presentations from the meeting that aim to address these issues. This meeting was co-organized by the European Society for Blood & Marrow Transplantation (EBMT) and European Hematology Association (EHA).
